Science
Why Buy Stock In EyePoint Pharmaceuticals Inc (EYPT)?
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) has a beta value of 1.63 and has seen 2.15 million shares traded in the last trading session. The company, currently
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) has a beta value of 1.63 and has seen 2.15 million shares traded in the last trading session. The company, currently
During the last session, EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)’s traded shares were 2.53 million, with the beta value of the company hitting 1.55. At the end
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)’s traded shares stood at 0.69 million during the last session, with the company’s beta value hitting 1.66. At the close of
© 2024, Powered by Smart TechOne